Lilly Anchors Oura's $2.2B IPO With $100M Stake
LLY sits 61% above its 52-week low of $712.05.
Summary
Oura, the smart ring maker, is launching a US IPO to raise up to $2.2 billion, selling 50 million shares at $40-$44 each. The IPO terms could push the company's market capitalization above $14 billion. Eli Lilly has indicated interest in buying up to $100 million of the offering, alongside Dragoneer's $300 million indication. This is a strategic move for Lilly, which has been expanding beyond pharmaceuticals into health tech and wearables. The IPO is expected to list on Nasdaq under 'OURA'. For Lilly, the $100 million stake is modest relative to its $1.08 trillion market cap, but it signals a deepening interest in consumer health data and digital health integration. The deal follows Lilly's recent acquisition of Merida Biosciences and its strong Q2 performance, reinforcing its diversification strategy.
At the time of this announcement, LLY was trading at $1,144.40 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.1T. The 52-week trading range was $712.05 to $1,292.65. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.